29 related articles for article (PubMed ID: 9257113)
1. PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice.
Holt MK; Cook DR; Brierley DI; Richards JE; Reimann F; Gourine AV; Marina N; Trapp S
Mol Metab; 2020 Sep; 39():101024. PubMed ID: 32446875
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 (GLP-1).
Müller TD; Finan B; Bloom SR; D'Alessio D; Drucker DJ; Flatt PR; Fritsche A; Gribble F; Grill HJ; Habener JF; Holst JJ; Langhans W; Meier JJ; Nauck MA; Perez-Tilve D; Pocai A; Reimann F; Sandoval DA; Schwartz TW; Seeley RJ; Stemmer K; Tang-Christensen M; Woods SC; DiMarchi RD; Tschöp MH
Mol Metab; 2019 Dec; 30():72-130. PubMed ID: 31767182
[TBL] [Abstract][Full Text] [Related]
3. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes.
Trahair LG; Horowitz M; Stevens JE; Feinle-Bisset C; Standfield S; Piscitelli D; Rayner CK; Deane AM; Jones KL
Diabetologia; 2015 Aug; 58(8):1769-78. PubMed ID: 26048234
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and hemodynamic effects of glucagon-like peptide-1.
Goodwill AG; Mather KJ; Conteh AM; Sassoon DJ; Noblet JN; Tune JD
Rev Endocr Metab Disord; 2014 Sep; 15(3):209-17. PubMed ID: 24881624
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs.
Nalin L; Selvaraju RK; Velikyan I; Berglund M; Andréasson S; Wikstrand A; Rydén A; Lubberink M; Kandeel F; Nyman G; Korsgren O; Eriksson O; Jensen-Waern M
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1800-10. PubMed ID: 24643781
[TBL] [Abstract][Full Text] [Related]
6. Incretins in type 2 diabetes mellitus: cardiovascular and anti-atherogenic effects beyond glucose lowering.
Psallas M; Manes C
Hippokratia; 2012 Apr; 16(2):100-5. PubMed ID: 23935263
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular biology of the incretin system.
Ussher JR; Drucker DJ
Endocr Rev; 2012 Apr; 33(2):187-215. PubMed ID: 22323472
[TBL] [Abstract][Full Text] [Related]
8. The effect of endogenously released glucose, insulin, glucagon-like peptide 1, ghrelin on cardiac output, heart rate, stroke volume, and blood pressure.
Hlebowicz J; Lindstedt S; Björgell O; Dencker M
Cardiovasc Ultrasound; 2011 Dec; 9():43. PubMed ID: 22206473
[TBL] [Abstract][Full Text] [Related]
9. Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study.
Gill A; Hoogwerf BJ; Burger J; Bruce S; Macconell L; Yan P; Braun D; Giaconia J; Malone J
Cardiovasc Diabetol; 2010 Jan; 9():6. PubMed ID: 20109208
[TBL] [Abstract][Full Text] [Related]
10. Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?
Grieve DJ; Cassidy RS; Green BD
Br J Pharmacol; 2009 Aug; 157(8):1340-51. PubMed ID: 19681866
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal hormones regulating appetite.
Chaudhri O; Small C; Bloom S
Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1187-209. PubMed ID: 16815798
[TBL] [Abstract][Full Text] [Related]
12. GLP-1: target for a new class of antidiabetic agents?
Edwards CM
J R Soc Med; 2004 Jun; 97(6):270-4. PubMed ID: 15173327
[No Abstract] [Full Text] [Related]
13. Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.
Velasquez-Mieyer PA; Umpierrez GE; Lustig RH; Cashion AK; Cowan PA; Christensen M; Spencer KA; Burghen GA
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):330-3. PubMed ID: 14708034
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and pancreatic endocrine responses to glucagon-like peptide-1(7-36) amide in the conscious calf.
Edwards CM; Edwards AV; Bloom SR
Exp Physiol; 1997 Jul; 82(4):709-16. PubMed ID: 9257113
[TBL] [Abstract][Full Text] [Related]
15. Effects of certain metabolites on pancreatic endocrine responses to gastrin-releasing peptide in conscious calves.
Bloom SR; Edwards AV; Ghatei MA
J Physiol; 1984 Jan; 346():547-55. PubMed ID: 6366189
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic endocrine responses to the peptides VIP and PACAP in the conscious calf.
Edwards AV; Bloom SR; Ghatei MA
Exp Physiol; 1997 Jul; 82(4):717-27. PubMed ID: 9257114
[TBL] [Abstract][Full Text] [Related]
17. Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves.
Bloom SR; Edwards AV; Ghatei MA
J Physiol; 1983 Nov; 344():37-48. PubMed ID: 6361234
[TBL] [Abstract][Full Text] [Related]
18. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
19. [The entero-insular axis: the new incretin candidate glucagon-like peptide-1(7-36)amide (GLP-1(7-36))amide].
Göke R; Göke B; Richter G; Arnold R
Z Gastroenterol; 1988 Nov; 26(11):715-9. PubMed ID: 2849249
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
